Drug-induced lipodystrophy
ORPHA: 901571 Treatment Available
Overview
medical condition
Available Treatments (1)
| Drug | Form | Status | Countries | Lead Time |
|---|---|---|---|---|
| Metreleptin Orphan Cold Chain | Subcutaneous injection, 11.3mg powder for reconstitution | FDA Approved | 6 | 21d |
Clinical Presentation
Signs and symptoms associated with Drug-induced lipodystrophy, sourced from HPO and Orphanet clinical annotations.
LipoatrophyReduced subcutaneous adipose tissueAbsence of subcutaneous fatHyperpigmentation of the skinHypopigmentation of the skinErythema
Classification & Codes
Orphanet Code
ORPHA:90157Drug-induced lipodystrophy
| Orphanet | ORPHA:90157 |
| Treatments | 1 drug(s) |
| Symptoms on record | 6 signs |
| Status | published |
Treatment Summary
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO